Category: Medications - Page 3

Corticosteroid-induced hyperglycemia is a common but often overlooked side effect of steroid treatment. Learn how to monitor blood sugar, recognize warning signs, and manage insulin needs to prevent dangerous spikes and crashes.

Learn how one medication can change how your body processes another-through absorption, metabolism, or excretion. Simple steps to avoid dangerous drug interactions and stay safe.

Clarithromycin can cause deadly interactions with common drugs like colchicine, statins, and heart medications. Learn which combinations to avoid and safer alternatives that could save your life.

SSRIs help millions with depression and anxiety, but side effects like sexual dysfunction, weight gain, nausea, and discontinuation syndrome are common. Learn what to expect, how to manage them, and when to seek help.

Lithium is effective for bipolar disorder but dangerous when combined with NSAIDs, diuretics, or dehydration. Learn how common medications and everyday habits can trigger toxic lithium levels-and how to stay safe.

Pharmacists must stay current on generics to ensure safe substitutions. Learn the latest FDA guidelines, state CE requirements, and practical training methods to avoid dangerous errors in daily practice.

GLP-1 agonists like Wegovy and Zepbound offer stronger weight loss than older drugs like phentermine or orlistat, but come with higher costs, injections, and side effects. Learn which option fits your needs.

Clinician communication is the most powerful factor influencing whether patients accept generic medications. Clear, confident explanations about FDA standards and bioequivalence can reduce skepticism, improve adherence, and save billions in healthcare costs.

Drug safety signals often emerge only after a medication is approved and used by millions. Learn how clinical trials miss rare risks, how regulators detect hidden dangers, and why real-world data is now the key to protecting patients.

Generic drugs cost far less than brand-name versions because they avoid expensive R&D, rely on economies of scale, and operate under intense competition. This is why they make up 90% of U.S. prescriptions but only 16% of drug spending.